Table 4.
B | P value | 95%CI | |
---|---|---|---|
PACG | |||
IOP | 0.302 | < 0.001 | 0.271 to 0.332 |
AL | 0.665 | < 0.001 | 0.326 to 0.998 |
ACD | − 0.324 | 0.497 | − 1.260 to 0.612 |
CCT | 0.003 | 0.561 | − 0.006 to 0.012 |
Male PACG | |||
IOP | 0.315 | < 0.001 | 0.255 to 0.375 |
AL | 0.582 | 0.063 | − 0.031 to 1.196 |
ACD | 0.581 | 0.456 | − 0.948 to 2.109 |
CCT | 0.001 | 0.918 | − 0.016 to 0.017 |
Female PACG | |||
IOP | 0.295 | < 0.001 | 0.260 to 0.330 |
AL | 0.663 | 0.001 | 1.070 to 1.225 |
ACD | − 1.008 | 0.096 | − 2.196 to 0.180 |
CCT | 0.004 | 0.495 | − 0.007 to 0.014 |
Multiple linear regressions for associations between MD and ocular biometry in subjects with PACG after adjusting for age, IOP-lowering medications and gender. A significant positive correlation was found between the MD and IOP in the whole PACG group. However, a significant positive correlation was observed between the MD and AL in the female subgroup but not male subgroup
AL axial length, MD mean deviation values for the visual field, IOP intraocular pressure, 95%CI 95% confidence interval